| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88332586 | FILING DATE | 03/08/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | MCDORMAN, ROGER THOMAS |
L.O. ASSIGNED | 109 |
PUB INFORMATION |
|||
| RUN DATE | 03/10/2020 | ||
| PUB DATE | 07/16/2019 | ||
| STATUS | 748-STATEMENT OF USE - TO EXAMINER | ||
| STATUS DATE | 03/08/2020 | ||
| LITERAL MARK ELEMENT | XENLETA | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | XENLETA |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Nabriva Therapeutics US, Inc. |
| ADDRESS | 1000 Continental Drive, Suite 600 King of Prussia, PA 19406 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for treating respiratory illnesses; antibiotics; pharmaceutical preparations for the treatment of pneumonia and bacterial infections |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 09/00/2019 | FIRST USE IN COMMERCE DATE | 09/00/2019 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| TRANSLATION | The wording "XENLETA" has no meaning in a foreign language. |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 03/08/2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 031 |
| 02/19/2020 | IUAF | S | USE AMENDMENT FILED | 030 |
| 03/07/2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 029 |
| 02/20/2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 028 |
| 02/20/2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 027 |
| 02/20/2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 026 |
| 02/20/2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 025 |
| 02/20/2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 024 |
| 02/19/2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 023 |
| 02/19/2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 022 |
| 02/19/2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 021 |
| 02/19/2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 020 |
| 10/30/2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 019 |
| 10/30/2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 018 |
| 10/30/2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 017 |
| 09/10/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 016 |
| 07/16/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 015 |
| 07/16/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 014 |
| 06/26/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 013 |
| 06/12/2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 012 |
| 06/07/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 011 |
| 06/05/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 06/05/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 06/04/2019 | ALIE | A | ASSIGNED TO LIE | 008 |
| 05/30/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 05/22/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 05/22/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 05/22/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 05/16/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 03/27/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 03/12/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Jeffrey H. Greene |
| CORRESPONDENCE ADDRESS | Jeffrey H. Greene Cooley LLP 1299 Pennsylvania Avenue, Suite 700 Washington DC 20004 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Nabriva Therapeutics US, Inc. |
| ADDRESS | 1000 Continental Drive, Suite 600 King of Prussia, PA 19406 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |